The rechallenge experiments provide compelling evidence of the recall function of EphA3 CAR T cells, with a notable percentage of mice exhibiting tumor clearance on secondary tumor implantation without further CAR T cell treatment. This evidence concerns the gene EPHA3 and neoplasm.